- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Classical and innovative drugs for the treatment of Leishmania infections ; volume:21 ; number:1 ; day:7 ; month:10 ; year:2024 ; pages:1-12 ; date:12.2024
Discover public health ; 21, Heft 1 (7.10.2024), 1-12, 12.2024
- Creator
-
Mota, Wanessa J. S.
Guedes, Beatriz N.
Jain, Sona
Cardoso, Juliana C.
Severino, Patricia
Souto, Eliana B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12982-024-00247-1
- URN
-
urn:nbn:de:101:1-2412242115048.198988669786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mota, Wanessa J. S.
- Guedes, Beatriz N.
- Jain, Sona
- Cardoso, Juliana C.
- Severino, Patricia
- Souto, Eliana B.
- SpringerLink (Online service)
Other Objects (12)
Human genetics of leishmania infections
Leishmania infections: Molecular targets and diagnosis
Identification of asymptomatic Leishmania infections: a scoping review
Experimental infections of sand flies and geckos with Leishmania (Sauroleishmania) adleri and Leishmania (S.) hoogstraali
Identifying asymptomatic Leishmania infections in non-endemic villages in Gedaref state, Sudan
Dual-target drugs against Leishmania donovani for potential novel therapeutics
Comment on “Regulation of immunity during visceral Leishmania infection” and further discussions about the role of antibodies in infections with Leishmania
Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns
Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
Innovative drugs promote precision cancer therapy
Role of host cell- and parasite-derived arginase in murine Leishmania mexicana infections : = Rolle der Wirtszell- und Parasitenarginase bei Infektionen mit Leishmania mexicana im Mausmodell
Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally
Human genetics of leishmania infections
Leishmania infections: Molecular targets and diagnosis
Identification of asymptomatic Leishmania infections: a scoping review
Experimental infections of sand flies and geckos with Leishmania (Sauroleishmania) adleri and Leishmania (S.) hoogstraali
Identifying asymptomatic Leishmania infections in non-endemic villages in Gedaref state, Sudan
Dual-target drugs against Leishmania donovani for potential novel therapeutics
Comment on “Regulation of immunity during visceral Leishmania infection” and further discussions about the role of antibodies in infections with Leishmania
Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns
Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
Innovative drugs promote precision cancer therapy
Role of host cell- and parasite-derived arginase in murine Leishmania mexicana infections : = Rolle der Wirtszell- und Parasitenarginase bei Infektionen mit Leishmania mexicana im Mausmodell
Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally
Human genetics of leishmania infections
Leishmania infections: Molecular targets and diagnosis
Identification of asymptomatic Leishmania infections: a scoping review
Experimental infections of sand flies and geckos with Leishmania (Sauroleishmania) adleri and Leishmania (S.) hoogstraali
Identifying asymptomatic Leishmania infections in non-endemic villages in Gedaref state, Sudan
Dual-target drugs against Leishmania donovani for potential novel therapeutics
Comment on “Regulation of immunity during visceral Leishmania infection” and further discussions about the role of antibodies in infections with Leishmania
Leishmania infantum and Dirofilaria immitis infections in Italy, 2009–2019: changing distribution patterns
Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
Innovative drugs promote precision cancer therapy
Role of host cell- and parasite-derived arginase in murine Leishmania mexicana infections : = Rolle der Wirtszell- und Parasitenarginase bei Infektionen mit Leishmania mexicana im Mausmodell